Lamotriginevdispersible Tablets Suppliers & Bulk Manufacturers
Available Forms: Tablets(IR & ER)
Available Strengths: XR: 25 mg, 50 mg, 100 mg, 200 mg; IR: 25 mg, 100 mg, 200 mg, 300 mg
Reference Brands: Lamictal, Lamictal XR(EU & US)
Category: Multiple sclerosis
Lamotrigine dispersible tablets, both IR and ER, inhibit voltage-gated sodium channels, stabilizing neuronal membranes and reducing excitability. They effectively control seizures and stabilize mood in bipolar disorder. Benefits include flexible dosing, rapid absorption, ease of swallowing, improved adherence, and better symptom management, supporting long-term epilepsy and bipolar treatment.
Product Description:
Lamotrigine dispersible tablets, available as immediate-release (IR) and extended-release (ER), are approved in the US by the FDA and in the EU via EMA for epilepsy and bipolar disorder management. Regulatory approval requires comprehensive dossiers including clinical efficacy, safety profiles, manufacturing standards, and pharmacovigilance plans. In the US, the FDA reviews detailed clinical trial data and manufacturing processes, while the EMA ensures compliance with regional safety and quality regulations.
Lamotriginevdispersible Tablets — third party manufacturing & bulk supply
Lamotriginevdispersible Tablets is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:
What to include when you enquire
- Destination market — determines which manufacturers hold the right site-level approvals
- First order quantity and estimated annual volume
- Whether you need a registration dossier or the product is already registered
- Packaging, labelling and language requirements
- Incoterms and required shelf life
Manufacturers of Lamotriginevdispersible Tablets listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding. Narcotic drugs and controlled substances are supplied strictly against valid import and export permits issued by the competent authorities.
Request a quote for Lamotriginevdispersible Tablets →The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Frequently Asked Questions
Related Products
Dalfampridine
Strength:
10 mg
Form: Extended-Release tablets (XR)
Reference Brands: Ampyra(US)
View DetailsTizanidine Tablets/Capsules
Strength:
2 mg and 4 mg
Form: Oral Capsules/Tablets
Reference Brands: Zanaflex (US)
View DetailsBaclofen Tablets:
Strength:
10 mg and 20 mg
Form: Tablet
Reference Brands: Lioresal, Gablofen(US & EU)
View DetailsOfatumumab Injection
Strength:
20 mg/mL
Form: Injection(SQ)
Reference Brands: Kesimpta(US)
View DetailsQuick Response Guaranteed | Verified Suppliers